AAHKS, along with The Hip Society and The Knee Society, provided comments to the FDA on the Agency’s “Custom Device Exemption Draft Guidance for Industry and Food and Drug Administration Staff.” Our comments suggested modifications to the draft guidelines that would improve its clarity and consistency.
Categories
- AAHKS Amplified (4)
- AAHKS Business (119)
- AAHKS Leadership (63)
- Advocacy (164)
- AJRR (48)
- Annual Meeting (217)
- Arthroplasty Topics Podcast (30)
- Bundled Payments (12)
- Certification (1)
- CME (14)
- CMS (145)
- Co-Branded Meetings (14)
- Committees and Task Forces (28)
- Corporate Partners (25)
- COVID-19 (30)
- Digital Health (4)
- Digital Health Podcast (1)
- Diversity (3)
- Education (78)
- eMentor (4)
- Federal Guidelines (36)
- Fellowships (34)
- FOCAL (8)
- Foundation (15)
- Guidelines (7)
- Humanitarian Award (7)
- Humanitarian Organizations (17)
- In Memoriam (15)
- In the News (227)
- Industry (14)
- International (37)
- Legislation (60)
- Medicare (89)
- Membership (39)
- New Orthopaedic Headquarters (5)
- News Releases (8)
- Operation Walk (4)
- Opioids (7)
- Patient Education (42)
- Patient Outcomes (7)
- Performance Measures (16)
- Popular (51)
- Position Papers (8)
- Practice Management (23)
- Promotions (15)
- Publications (89)
- Research (177)
- Residents (27)
- Social Media (7)
- Specialty Day (7)
- Spring Meeting (43)
- Surveys (10)
- Technology (11)
- The Match (14)
- Uncategorized (21)
- Video (6)
- Webinars (38)
- Website (10)
- Women in Arthroplasty (8)
- Young Arthroplasty Group (2)